NASDAQ · SURG

SurgePays, Inc.

$0.24 -$0.00 (-1.65%) 1D Market open

Key Metrics

$6.05M
Market cap
P/E · TTM
$62.37M
Revenue · TTM
−$40.48M
Net income
EPS · TTM $-2.02
Dividend yield
Free cash flow
Beta · 1Y 1.01
EBITDA · TTM −$40.34M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its Feb 2 high, the share price fell 79%.

    Peak close $1.15 on Feb 2; trough close $0.24 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -79%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 2
    The stock moved +38.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 2
  • Apr 15
    The stock moved -33.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 15

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$6.05M
Enterprise value$36.26M
Shares outstanding25.1M
52-wk range$0.23 – $3.22
Avg volume · 20D597.2K
Net cash −$30.21M
Book value / share$-1.19
IndustryTelephone Communications (No Radiotelephone)
ExchangeNASDAQ
About SurgePays, Inc.
IPO dateMay 8, 2007
Employees20

Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.10
P/FCF
EV/EBITDA
EV/Sales0.58
Graham №

Profitability

Gross
Operating -64.9%
Net -64.9%
FCF
ROE / ROIC 952.9% · —

Financial Health

Current ratio0.27
Quick ratio0.26
Debt / equity-1.35
Debt / EBITDA -0.80
Net cash −$30.21M
Working capital−$21.83M

Cash Flow · TTM

Operating CF −$18.88M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

-26.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings